Published in BMC Gastroenterol on June 29, 2010
Current status of molecular markers for early detection of sporadic pancreatic cancer. Biochim Biophys Acta (2010) 1.58
Advances in biomarker research for pancreatic cancer. Curr Pharm Des (2012) 1.05
Clinical and technical phosphoproteomic research. Proteome Sci (2011) 1.04
Serum biomarkers identification by mass spectrometry in high-mortality tumors. Int J Proteomics (2013) 0.83
Plasma proteomics shows an elevation of the anti-inflammatory protein APOA-IV in chronic equine laminitis. BMC Vet Res (2012) 0.81
An integrative proteomics and interaction network-based classifier for prostate cancer diagnosis. PLoS One (2013) 0.79
Proteomics analysis of bodily fluids in pancreatic cancer. Proteomics (2015) 0.78
Screening technologies for target identification in pancreatic cancer. Cancers (Basel) (2010) 0.77
Quantitative Analysis of Differential Proteome Expression in Bladder Cancer vs. Normal Bladder Cells Using SILAC Method. PLoS One (2015) 0.76
Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach. PLoS One (2015) 0.75
Pancreatic Cancer: a Challenge to Cure. Indian J Surg (2015) 0.75
2D-DIGE as a strategy to identify serum biomarkers in Mexican patients with Type-2 diabetes with different body mass index. Sci Rep (2017) 0.75
Proteomics in pancreatic cancer research. Int J Proteomics (2011) 0.75
Cancer statistics, 2005. CA Cancer J Clin (2005) 25.65
Pancreatic cancer. Lancet (2004) 11.63
A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics (2003) 3.57
Asymmetric distribution of myosin IIB in migrating endothelial cells is regulated by a rho-dependent kinase and contributes to tail retraction. Mol Biol Cell (2003) 1.85
The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Eur J Surg Oncol (2005) 1.77
Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens (2006) 1.66
A fluorescent resonant energy transfer-based biosensor reveals transient and regional myosin light chain kinase activation in lamella and cleavage furrows. J Cell Biol (2002) 1.53
Mannan-binding lectin (MBL) polymorphism and gastric cancer risk in Japanese population. Dig Dis Sci (2008) 1.49
Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. J Proteome Res (2005) 1.24
Clinicopathological aspects of small pancreatic cancer. Pancreas (2004) 1.18
Myosin light chain kinase inhibitors can block invasion and adhesion of human pancreatic cancer cell lines. Pancreas (2002) 1.15
Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 1.11
Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity gene. J Natl Cancer Inst (2007) 1.05
Surgical management of pancreatic cancer. Oncology (Williston Park) (2002) 1.05
Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1/2. Cancer Lett (2008) 1.05
Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells. BMC Microbiol (2008) 1.01
Extraordinarily elevated CA19-9 in benign conditions: a case report and review of the literature. Tumori (2001) 0.99
Increased expression of myosin light chain kinase mRNA is related to metastasis in non-small cell lung cancer. Tumour Biol (2005) 0.98
Molecular diagnosis of early pancreatic ductal adenocarcinoma in high-risk patients. Pancreatology (2001) 0.95
MBL2 and MASP2 gene polymorphisms in patients with hepatocellular carcinoma. J Viral Hepat (2008) 0.94
Matrix metalloproteinase-2 in pancreatic juice for diagnosis of pancreatic cancer. Pancreas (2002) 0.92
Angiogenesis and antiangiogenic strategies in pancreatic cancer. Int J Gastrointest Cancer (2003) 0.91
Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations. Am J Gastroenterol (1999) 0.91
The mannose-binding lectin (MBL2) haplotype and breast cancer: an association study in African-American and Caucasian women. Carcinogenesis (2006) 0.90
Inhibiting myosin light chain kinase retards the growth of mammary and prostate cancer cells. Eur J Cancer (2006) 0.89
Small carcinoma of the pancreas. Factors of prognostic relevance. J Hepatobiliary Pancreat Surg (1998) 0.87
Enzyme-linked PNA lectin binding assay compared with CA19-9 and CEA radioimmunoassay as a diagnostic blood test for pancreatic cancer. Br J Cancer (1989) 0.84
Tumor size as a predictive factor. Int J Pancreatol (1991) 0.81
Plasma miRNAs Effectively Distinguish Patients With Pancreatic Cancer From Controls: A Multicenter Study. Ann Surg (2016) 1.66
Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J Proteome Res (2010) 1.47
Image fusion with guided filtering. IEEE Trans Image Process (2013) 1.45
Effect of dietary fiber and growth hormone on colonic adaptation in short bowel syndrome treated by enteral nutrition. World J Surg (2008) 1.41
Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells. Tumour Biol (2013) 1.34
Single-nanocrystal sensitivity achieved by enhanced upconversion luminescence. Nat Nanotechnol (2013) 1.27
CTGF is overexpressed in papillary thyroid carcinoma and promotes the growth of papillary thyroid cancer cells. Tumour Biol (2011) 0.98
Granulocytic sarcoma of the pancreas: a case report and review of the literatures. BMC Gastroenterol (2010) 0.97
Comparative structural analysis of the glycosylation of salivary and buccal cell proteins: innate protection against infection by Candida albicans. Glycobiology (2012) 0.93
Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis. Cancer Sci (2009) 0.93
A phase I pilot trial of MUC1-peptide-pulsed dendritic cells in the treatment of advanced pancreatic cancer. Clin Exp Med (2011) 0.92
Connective tissue growth factor enhances the migration of gastric cancer through downregulation of E-cadherin via the NF-κB pathway. Cancer Sci (2010) 0.91
Effect of CCR7, CXCR4 and VEGF-C on the lymph node metastasis of human pancreatic ductal adenocarcinoma. Oncol Lett (2013) 0.91
A proteomic study of the aortic media in human thoracic aortic dissection: implication for oxidative stress. J Thorac Cardiovasc Surg (2008) 0.91
Upconversion luminescence with tunable lifetime in NaYF4:Yb,Er nanocrystals: role of nanocrystal size. Nanoscale (2012) 0.90
Ultrabright Eu-doped plasmonic Ag@SiO2 nanostructures: time-gated bioprobes with single particle sensitivity and negligible background. Adv Mater (2011) 0.87
Achieving λ/10 resolution CW STED nanoscopy with a Ti:Sapphire oscillator. PLoS One (2012) 0.86
Induction of protective and therapeutic anti-pancreatic cancer immunity using a reconstructed MUC1 DNA vaccine. BMC Cancer (2009) 0.86
Multicolor barcoding in a single upconversion crystal. J Am Chem Soc (2014) 0.85
Differentiating vitreous proteomes in proliferative diabetic retinopathy using high-performance liquid chromatography coupled to tandem mass spectrometry. Exp Eye Res (2012) 0.84
Liver transplant patients have a risk of progression similar to that of sporadic patients with branch duct intraductal papillary mucinous neoplasms. Liver Transpl (2014) 0.83
Time-gated orthogonal scanning automated microscopy (OSAM) for high-speed cell detection and analysis. Sci Rep (2012) 0.83
TRAF6 is over-expressed in pancreatic cancer and promotes the tumorigenicity of pancreatic cancer cells. Med Oncol (2014) 0.82
Automated detection of rare-event pathogens through time-gated luminescence scanning microscopy. Cytometry A (2011) 0.82
IRF-2 is over-expressed in pancreatic cancer and promotes the growth of pancreatic cancer cells. Tumour Biol (2011) 0.82
New class of tetradentate β-diketonate-europium complexes that can be covalently bound to proteins for time-gated fluorometric application. Bioconjug Chem (2012) 0.82
Europium chelate (BHHCT-Eu3+) and its metal nanostructure enhanced luminescence applied to bioassays and time-gated bioimaging. Langmuir (2010) 0.82
Calibration beads containing luminescent lanthanide ion complexes. J Biomed Opt (2009) 0.82
Expression of CK19 and KIT in resectable pancreatic neuroendocrine tumors. Tumour Biol (2013) 0.82
Parallel imaging and compressed sensing combined framework for accelerating high-resolution diffusion tensor imaging using inter-image correlation. Magn Reson Med (2014) 0.81
Primary small cell carcinoma of the pancreas: rare type of pancreatic cancer and review of the literatures. World J Surg Oncol (2012) 0.81
High intensity solid-state UV source for time-gated luminescence microscopy. Cytometry A (2006) 0.81
Resolving low-expression cell surface antigens by time-gated orthogonal scanning automated microscopy. Anal Chem (2012) 0.81
Enhanced flow cytometry-based bead immunoassays using metal nanostructures. Anal Chem (2009) 0.81
Expression of PTEN and mTOR in pancreatic neuroendocrine tumors. Tumour Biol (2013) 0.81
Clinicopathological characteristics and prognosis-related factors of resectable pancreatic neuroendocrine tumors: a retrospective study of 104 cases in a single Chinese center. Pancreas (2014) 0.79
Development of a visible-light-sensitized europium complex for time-resolved fluorometric application. Anal Chem (2010) 0.79
Laser oblique scanning optical microscopy (LOSOM) for phase relief imaging. Opt Express (2012) 0.79
Analytical description of high-aperture STED resolution with 0-2π vortex phase modulation. J Opt Soc Am A Opt Image Sci Vis (2013) 0.79
PROMISE: parallel-imaging and compressed-sensing reconstruction of multicontrast imaging using SharablE information. Magn Reson Med (2014) 0.79
Application of exonuclease III-aided target recycling in flow cytometry: DNA detection sensitivity enhanced by orders of magnitude. Anal Chem (2013) 0.78
Analysis of protein-protein interactions and proteomic profiles of normal human lenses. Curr Eye Res (2010) 0.78
Preparation and time-gated luminescence bioimaging application of ruthenium complex covalently bound silica nanoparticles. Talanta (2009) 0.78
Preparation and time-gated luminescence bioimaging applications of long wavelength-excited silica-encapsulated europium nanoparticles. Nanoscale (2012) 0.78
[Therapeutic effects of human interleukin 10 gene transfer on severe acute pancreatitis in rats, an experimental study]. Zhonghua Yi Xue Za Zhi (2002) 0.78
Development of a functional ruthenium(II) complex for probing hypochlorous acid in living cells. Dalton Trans (2014) 0.78
CRAFT: Multimodality confocal skin imaging for early cancer diagnosis. J Biophotonics (2012) 0.78
Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma. Ann Surg (2017) 0.77
Homologous HOmologous Black-Bright-blood and flexible Interleaved imaging sequence (HOBBI) for dynamic contrast-enhanced MRI of the vessel wall. Magn Reson Med (2014) 0.77
Luminescent europium nanoparticles with a wide excitation range from UV to visible light for biolabeling and time-gated luminescence bioimaging. Chem Commun (Camb) (2008) 0.77
Preparation and time-resolved luminescence bioassay application of multicolor luminescent lanthanide nanoparticles. J Fluoresc (2009) 0.77
Observation of mesenteric microcirculatory disturbance in rat by laser oblique scanning optical microscopy. Sci Rep (2013) 0.77
Developing red-emissive ruthenium(II) complex-based luminescent probes for cellular imaging. Bioconjug Chem (2012) 0.76
The value of serum chromogranin A as a predictor of tumor burden, therapeutic response, and nomogram-based survival in well-moderate nonfunctional pancreatic neuroendocrine tumors with liver metastases. Eur J Gastroenterol Hepatol (2015) 0.76
Photoluminescent and electrochemiluminescent dual-signaling probe for bio-thiols based on a ruthenium(II) complex. Anal Chim Acta (2012) 0.76
Association between cytochrome P450 2C9 gene polymorphisms and colorectal cancer susceptibility: evidence from 16 case-control studies. Tumour Biol (2014) 0.76
Differential proteomics analysis of female and male adults of Angiostrongylus cantonensis. Exp Parasitol (2012) 0.76
Clinical Analysis and Comprehensive Treatment of Nonfunctional Pancreatic Neuroendocrine Tumor With Liver Metastases: A Retrospective Single-Center Study. Pancreas (2015) 0.76
Prognostic value of histological subtype in intraductal papillary mucinous neoplasm of the pancreas: A retrospective analysis of outcome from one single center. Medicine (Baltimore) (2017) 0.75
Magnetically targeted delivery of DOX loaded Cu9S5@mSiO2@Fe3O4-PEG nanocomposites for combined MR imaging and chemo/photothermal synergistic therapy. Nanoscale (2015) 0.75
Background free imaging of upconversion nanoparticle distribution in human skin. J Biomed Opt (2013) 0.75
An analysis of clinico-pathologic features of intraductal papillary mucinous neoplasm of the pancreas. Front Med China (2007) 0.75
[Anti-tumor effect through human endostatin gene transfer in mice bearing B16 melanoma]. Zhonghua Zhong Liu Za Zhi (2002) 0.75
Tuning Enhancement Efficiency of Multiple Emissive Centres in Graphene Quantum Dots by Core-Shell Plasmonic Nanoparticles. J Phys Chem Lett (2017) 0.75
DNA-PKcs deficiency sensitizes the human hepatoma HepG2 cells to cisplatin and 5-fluorouracil through suppression of the PI3K/Akt/NF-κB pathway. Mol Cell Biochem (2014) 0.75
Lanthanide upconversion within microstructured optical fibers: improved detection limits for sensing and the demonstration of a new tool for nanocrystal characterization. Nanoscale (2012) 0.75
A versatile upconversion surface evaluation platform for bio-nano surface selection for the nervous system. Nanoscale (2017) 0.75
Schlieren confocal microscopy for phase-relief imaging. Opt Lett (2014) 0.75
[Correlation between dissemination growth pattern in invasive front and risk of lymph node metastasis in papillary thyroid carcinoma]. Zhonghua Bing Li Xue Za Zhi (2015) 0.75
IL-8-Positive Tumor-Infiltrating Inflammatory Cells Are a Novel Prognostic Marker in Pancreatic Ductal Adenocarcinoma Patients. Pancreas (2016) 0.75
Upconversion in NaYF(4):Yb, Er nanoparticles amplified by metal nanostructures. Nanotechnology (2011) 0.75
[Joint correction for motion artifacts and off-resonance artifacts in multi-shot diffusion magnetic resonance imaging]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi (2014) 0.75
One Hundred Twenty-One Resected Solid Pseudopapillary Tumor of the Pancreas: An 8-Year Single-Institution Experience at Zhongshan Hospital, Shanghai, China. Pancreas (2017) 0.75